Aug 11, 2022 / 12:30PM GMT
Operator
Greetings, and welcome to the CorMedix Inc. Second Quarter 2022 Earnings Call. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Dan Ferry from Life Science Advisors. Please go ahead.
Daniel Ferry - LifeSci Advisors, LLC - MD & Relationship Manager
Good morning. And welcome to the CorMedix Second Quarter 2022 Earnings Conference Call. Leading the call today is Joe Todisco, Chief Executive Officer of CorMedix. And he is joined by Dr. Matt David, Executive Vice President and CFO; Dr. Phoebe Mounts, EVP, General Counsel; and Head of Technical Operations, Erin Mistry, SVP of Commercial.
Before we begin, I would like to remind everyone that during the call, management may make what are known as forward-looking statements within the meaning set forth in the Private Securities Litigation Reform Act of 1995.
These statements are subject to certain risks and uncertainties and include, but are not limited to, any of the following: any statements other than statements
Q2 2022 CorMedix Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
